Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Stopped Study accrual rate is very slow, it was mandated by NCI to be terminated.

Conditions

• Pancreatic Cancer

Interventions

• DRUG: S-1
• DRUG: gemcitabine hydrochloride

Sponsor

Andrew Ko

Collaborators

• [object Object]
• [object Object]